Works matching DE "MYELOFIBROSIS"
Results: 2083
Ruxolitinib for Myelofibrosis: From 'Palliation' to Prolongation of Survival.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 717
- By:
- Publication type:
- Article
Improving Disease Burden in Myelofibrosis: Changing the Natural History of the Disease.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 715
- By:
- Publication type:
- Article
Clarifying the Use of Ruxolitinib in Patients With Myelofibrosis.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 706
- By:
- Publication type:
- Article
Recurrent Upper Gastrointestinal Bleeding from Isolated Gastric Varices as Primary Symptom of Myelofibrosis: A Case Report on Combining Interventional and Pharmacologic Treatment Options.
- Published in:
- Digestive Diseases, 2022, v. 40, n. 4, p. 530, doi. 10.1159/000518766
- By:
- Publication type:
- Article
Unique Challenges to Diagnosing Human Herpesvirus-6 (HHV-6) Encephalitis Following Post-Hematopoietic Stem Cell Transplant: A Case and Brief Review.
- Published in:
- Cell Transplantation, 2022, v. 31, p. 1, doi. 10.1177/09636897221119734
- By:
- Publication type:
- Article
Bevacizumab may be Active in Myelofibrosis.
- Published in:
- Cancer Investigation, 2010, v. 28, n. 1, p. 111, doi. 10.3109/07357900902918502
- By:
- Publication type:
- Article
STEM CELL RESCUE AFTER BONE MARROW REAMING FOR THE TREATMENT OF MYELOFIBROSIS WITH MYELOID METAPLASIA.
- Published in:
- 2001
- Publication type:
- Abstract
Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey.
- Published in:
- Turkish Journal of Medical Sciences, 2021, v. 51, n. 3, p. 1033, doi. 10.3906/sag-1812-70
- By:
- Publication type:
- Article
JAK2 V617F mutation in Iranian patients with myeloproliferative neoplasms: clinical and laboratory findings.
- Published in:
- Turkish Journal of Medical Sciences, 2013, v. 43, n. 3, p. 347, doi. 10.3906/sag-1205-11
- By:
- Publication type:
- Article
Red Blood Cell Distribution Width May Predict Drug-Induced Anemia and Prognosis in Patients Affected by Primary/Secondary Myelofibrosis Treated with Ruxolitinib.
- Published in:
- Oncology & Therapy, 2025, v. 13, n. 1, p. 165, doi. 10.1007/s40487-024-00322-2
- By:
- Publication type:
- Article
Outflanking missile defences: the Nuclear Non-proliferation Treaty, nuclear weapons and terrorism.
- Published in:
- Defense & Security Analysis, 2012, v. 28, n. 1, p. 81, doi. 10.1080/14751798.2012.651381
- By:
- Publication type:
- Article
Medication Adherence and Asthma Control with Once-Daily Indacaterol/Glycopyrronium/Mometasone Furoate Breezhaler Digital Companion: 90-Day Analysis from Germany.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Special evolution in myelofibrosis – case reports.
- Published in:
- Oncolog-Hematolog, 2022, n. 61, p. 8
- By:
- Publication type:
- Article
ASCO News 2015.
- Published in:
- Oncolog-Hematolog, 2015, n. 31, p. 36
- By:
- Publication type:
- Article
Treatment of patients with primary myelofibrosis using dasatinib.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2017, v. 21, n. 14, p. 3312
- By:
- Publication type:
- Article
Evaluation of Ruxolitinib versus Best Available Therapy in Treating Primary Myelofibrosis.
- Published in:
- Sultan Qaboos University Medical Journal, 2022, v. 22, n. 3, p. 393, doi. 10.18295/SQUMJ.8.2021.110
- By:
- Publication type:
- Article
Breakthrough <italic>Exophiala dermatitidis</italic> infection during prophylactic administration of micafungin during second umbilical cord blood transplantation after graft failure.
- Published in:
- Transplant Infectious Disease, 2018, v. 20, n. 2, p. 1, doi. 10.1111/tid.12833
- By:
- Publication type:
- Article
The Effect of Extremely Low-Frequency Magnetic Field on Stroke Patients: A Systematic Review.
- Published in:
- Brain Sciences (2076-3425), 2024, v. 14, n. 5, p. 430, doi. 10.3390/brainsci14050430
- By:
- Publication type:
- Article
Case report: Peri-procedural hydroxyurea helps minimize bleeding in patients with Essential Thrombocythemia associated with acquired von Willebrand syndrome.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1326209
- By:
- Publication type:
- Article
A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1265022
- By:
- Publication type:
- Article
The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1277453
- By:
- Publication type:
- Article
The molecular profile in patients with polycythemia vera and essential thrombocythemia is dynamic and correlates with disease’s phenotype.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1224590
- By:
- Publication type:
- Article
The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosis.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1190305
- By:
- Publication type:
- Article
Characterization of engraftment dynamics in myelofibrosis after allogeneic hematopoietic cell transplantation including novel conditioning schemes.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1205387
- By:
- Publication type:
- Article
Epigenetics in myeloproliferative neoplasms.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1206965
- By:
- Publication type:
- Article
Mutations, inflammation and phenotype of myeloproliferative neoplasms.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1196817
- By:
- Publication type:
- Article
Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1176173
- By:
- Publication type:
- Article
Case Report: Infectious prophylaxis in hematological malignancies.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1163175
- By:
- Publication type:
- Article
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1141610
- By:
- Publication type:
- Article
A predictive model for identifying secondary underlying diseases of hemophagocytic lymphohistiocytosis.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1143181
- By:
- Publication type:
- Article
Case Report: Molecular autopsy underlie COVID-19-associated sudden, unexplained child mortality.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1121059
- By:
- Publication type:
- Article
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1017863
- By:
- Publication type:
- Article
Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.768592
- By:
- Publication type:
- Article
Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.852158
- By:
- Publication type:
- Article
Impact of Red Blood Cell Transfusions on Quality of Life for Patients With Myelofibrosis in the SIMPLIFY-1 and SIMPLIFY-2 Clinical Trials.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2023, v. 14, n. 11, p. 357
- By:
- Publication type:
- Article
MOMENTUM: Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 11, p. 377
- By:
- Publication type:
- Article
Thrombocytopenic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor in a Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) (MOMENTUM).
- Published in:
- Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 11, p. 388
- By:
- Publication type:
- Article
Sotatercept, a First-in-Class Agent, Improves Hemoglobin Levels in Anemic Patients with Myelofibrosis.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2018, v. 9, n. 4, p. 162
- Publication type:
- Article
A Case of TAFRO Syndrome Developed after COVID-19 Vaccination.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Myelofibrosis associated with systemic lupus erythematosus successfully treated with rituximab.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Comment on published article in Lupus: Autoimmune myelofibrosis with pancytopenia as a presenting manifestation of systemic lupus erythematosus responsive to mycophenolate mofetil; IVIG in myelofibrosis in SLE.
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor
Autoimmune myelofibrosis with pancytopenia as a presenting manifestation of systemic lupus erythematosus responsive to mycophenolate mofetil.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Lytic bone lesions in lupus-associated myelofibrosis.
- Published in:
- Lupus, 2010, v. 19, n. 3, p. 313
- By:
- Publication type:
- Article
Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci?
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 7, p. 1616, doi. 10.1002/ijc.33337
- By:
- Publication type:
- Article
Lifestyle factors and risk of myeloproliferative neoplasms in the NIH‐AARP diet and health study.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 4, p. 948, doi. 10.1002/ijc.32853
- By:
- Publication type:
- Article
Inhibition of interleukin-1β reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32927-4
- By:
- Publication type:
- Article
Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32986-7
- By:
- Publication type:
- Article
A lymphatic-absorbed multi-targeted kinase inhibitor for myelofibrosis therapy.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32486-8
- By:
- Publication type:
- Article
Unilateral Subhyaloid Hemorrhage as a Presenting Sign of Chronic Myeloid Leukemia.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
A Rare Case of Spontaneous Tumor Lysis Syndrome in Idiopathic Primary Myelofibrosis.
- Published in:
- 2019
- By:
- Publication type:
- Case Study